InxMed IN10018 at ASCO 2022 demonstrates robust efficacy in patients with platinum-resistant recurrent ovarian cancer
NANJING, China, May 29, 2022 /PRNewswire/ — InxMed Co., Ltd, a clinical-stage biotechnology company dedicates on developing innovative…